Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1102, pseudogene (RNU6-1102P)
- Target
- RNU6-1102P
- Molecular classification
- Pseudogene, Small nuclear RNA (snRNA) pseudogene, Non-coding RNA pseudogene
01
Overview
RNA, U6 small nuclear 1102, pseudogene (RNU6-1102P) represents a genomic locus derived from the U6 small nuclear RNA (snRNA) gene but is classified as a pseudogene and is not believed to produce a functional RNA product[4]. U6 snRNA is a highly conserved, non-coding RNA component of the spliceosome, essential for pre-mRNA splicing in eukaryotes[1][3]. Many U6-related pseudogenes, such as RNU6-1102P, are the result of genomic retrotransposition events mediated by LINE-1 elements, which generate non-functional copies of snRNA genes scattered throughout the genome[2][5]. These pseudogenes lack the ability to participate in spliceosomal function and are not considered relevant drug targets. Some research uses the distribution and structure of U6 pseudogenes to study genome evolution and retrotransposon dynamics[2].
- Other names
- RNU6-1102PRNA, U6 small nuclear 1102, pseudogene
02
Mechanism of action
None; there is no documented mechanism of action, as this pseudogene does not function as a molecular drug target.
03
Biological functions
No biological functionPseudogenes generally do not produce functional RNA or protein productsRare regulatory roles are sometimes described for pseudogenes (not documented for this specific locus)
04
Disease associations
Not documentedPseudogenes of U6 snRNA, including RNU6-1102P, have no reported direct disease association or roleSome research uses snRNA pseudogenes as markers of retrotransposition activity within genomes
05
Biomarkers
None used for patient selection or efficacy monitoringPseudogenes, in some contexts, may be used as genomic markers for retrotransposition or evolutionary studies, but not as clinical biomarkers
Beyond the preview
Go deeper on RNA, U6 small nuclear 1102, pseudogene (RNU6-1102P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 1102, pseudogene (RNU6-1102P).